HOME >> MEDICINE >> NEWS
Northwestern Memorial helping to define best treatment for congestive heart failure

CHICAGO -- Northwestern Memorial Hospital (NMH) is the only Chicago-area hospital participating in a National Institutes of Health sponsored research study to find a definitive answer to whether medical therapy or surgery is the better option for treating congestive heart failure. In addition, the study will compare coronary artery bypass surgery alone to bypass surgery plus a new procedure called surgical ventricular restoration to see if the combined procedure increases long-term survival and decreases cardiac hospitalization.

The STICH (Surgical Treatments of Ischemic Heart Failure) trial is a worldwide study that will enroll about 2,800 patients at 90 leading medical centers around the world. "Heart failure affects about 5 million Americans and is the most common reason patients seek medical treatment at hospitals," says NMH's lead investigator, Mihai Gheorghiade, M.D., associate chief of the division of cardiology at Northwestern Memorial Hospital and professor of medicine at the Feinberg School of Medicine, Northwestern University. "Although we've made significant progress with medical therapies for heart failure, the mortality and hospitalizations continue to be unacceptably high. Cardiac transplantation is an option for patients with very severe heart failure, but very few patients (fewer than 2000 per year) receive this treatment due to the small number of donors. The present study is exploring the potential benefits of a new and revolutionary procedure, ventricular reconstruction."

Participants in the research study will have a cardiac MRI (magnetic resonance imaging) to produce a picture of their heart's structure and function. "Cardiac MRI is making a critical difference in our ability to treat heart failure patients. We can now pinpoint exactly where the problem lies, making it possible to identify candidates and treat the problem with surgical ventricular restoration," says Keith Horvath, M.D., a cardiovascular surgeon at NMH who is
'"/>

Contact: Amanda Widtfeldt
awidtfel@nmh.org
312-926-2955
Northwestern Memorial Hospital
17-Nov-2003


Page: 1 2

Related medicine news :

1. Northwestern Memorial Hospital honored with one of the nations top awards for quality
2. Northwestern Memorial physicians encourage screenings during colon cancer awareness month
3. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
4. Northwestern Memorial chosen to be featured in first-ever mini-med school TV airing on PBS
5. Countrys first simplified maze using new ultrasound technology is done at Northwestern Memorial
6. Northwestern Memorial Hospital testing new procedure for patients with major depression
7. Northwestern University receives $7.5 million for regenerative medicine
8. Northwestern researchers pinpoint how false memories are formed
9. Northwestern receives $2.1 million grant for Parkinsons disease research
10. Northwestern Memorial named one of nations top 12 hospital-affiliated infertility clinics
11. Blood pressure control poor in elderly, says Northwestern researcher

Post Your Comments:
(Date:9/4/2015)... ... , ... Mike Day, a former Navy SEAL who was shot 27 times ... in Kona on October 10th. , Mike is running the race to raise awareness ... the cutting-edge treatments that restore their quality of life. More than 300,000 ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Having access to ... has led to an increasing amount of unnecessary emergency room visits which affects hospitals’ ... taxes the country’s health bill. Fortunately, a solution to alleviate this problem has recently ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... are prophetic details involving the Pope’s upcoming trip to the United States. , Yisrayl lays ... his role with the Vatican and society is. Yisrayl also provides the meaning of his ...
(Date:9/3/2015)... ... ... While bariatric surgeon Michael Feiz, M.D., F.A.C.S. notes that he advises all ... some patients have been recently asking further questions relating to the best way to ... surgery that should be followed in the days prior to the procedure, Dr. Feiz ...
(Date:9/3/2015)... ... 03, 2015 , ... The Oregon Collaborative for Integrative Medicine ... & Medicine (AIHM) Interprofessional Fellowship in Integrative Health & Medicine. The AIHM Fellowship ... renowned educator, physician and thought leader in integrative medicine. This is the first ...
Breaking Medicine News(10 mins):Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3
(Date:9/4/2015)... LONDON , September 4, 2015 ... & Vaccines  Allergic Rhinitis drugs ... revenues Where is the market for allergic ... this market? Visiongain ,s new report shows you ... opportunities and prospects. Our 326 page report ...
(Date:9/4/2015)... Sep. 04, 2015 Research and ... "Investigation Report on China,s Sodium Ibandronate Market, 2010-2019" ... in the clinic under the trade name of Bondronat in ... in 1996, sodium ibandronate was approved by the FDA ... osteoporosis under the trade name of Boniva. However, since drug ...
(Date:9/4/2015)... , September 4, 2015 ... today announces that Hutchison MediPharma Limited ("HMP"), its ... in the second proof-of-concept ("POC") trial of fruquintinib ... cancer ("NSCLC") in China . ... succeeded in meeting the primary efficacy endpoint of ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
Cached News: